Palladium Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,332
| Closed | -$208K | – | 300 |
|
|
2021
Q2 | $208K | Sell |
1,332
-89
| -6% | -$13.9K | 0.01% | 277 |
|
|
2021
Q1 | $221K | Hold |
1,421
| – | – | 0.01% | 267 |
|
|
2020
Q4 | $213K | Buy |
+1,421
| New | +$213K | 0.01% | 245 |
|
|
2020
Q1 | – | Sell |
-1,575
| Closed | -$229K | – | 265 |
|
|
2019
Q4 | $229K | Sell |
1,575
-415
| -21% | -$60.3K | 0.01% | 246 |
|
|
2019
Q3 | $254K | Buy |
1,990
+214
| +12% | +$27.3K | 0.02% | 231 |
|
|
2019
Q2 | $203K | Sell |
1,776
-25
| -1% | -$2.86K | 0.01% | 256 |
|
|
2019
Q1 | $223K | Buy |
+1,801
| New | +$223K | 0.02% | 245 |
|
|
2018
Q4 | – | Sell |
-1,990
| Closed | -$254K | – | 258 |
|
|
2018
Q3 | $254K | Buy |
+1,990
| New | +$254K | 0.02% | 241 |
|
|
2018
Q2 | – | Sell |
-1,932
| Closed | -$205K | – | 271 |
|
|
2018
Q1 | $205K | Sell |
1,932
-581
| -23% | -$61.6K | 0.02% | 261 |
|
|
2017
Q4 | $294K | Hold |
2,513
| – | – | 0.02% | 227 |
|
|
2017
Q3 | $286K | Sell |
2,513
-63
| -2% | -$7.17K | 0.02% | 226 |
|
|
2017
Q2 | $321K | Buy |
2,576
+42
| +2% | +$5.23K | 0.03% | 214 |
|
|
2017
Q1 | $300K | Hold |
2,534
| – | – | 0.02% | 218 |
|
|
2016
Q4 | $254K | Hold |
2,534
| – | – | 0.02% | 226 |
|
|
2016
Q3 | $320K | Hold |
2,534
| – | – | 0.03% | 207 |
|
|
2016
Q2 | $296K | Buy |
2,534
+280
| +12% | +$32.7K | 0.03% | 205 |
|
|
2016
Q1 | $233K | Hold |
2,254
| – | – | 0.02% | 215 |
|
|
2015
Q4 | $224K | Buy |
+2,254
| New | +$224K | 0.02% | 225 |
|
|
2015
Q2 | – | Sell |
-1,773
| Closed | -$202K | – | 250 |
|
|
2015
Q1 | $202K | Buy |
+1,773
| New | +$202K | 0.02% | 248 |
|
|
2014
Q2 | – | Sell |
-1,773
| Closed | -$163K | – | 472 |
|
|
2014
Q1 | $163K | Buy |
+1,773
| New | +$163K | 0.01% | 260 |
|
|
2013
Q4 | – | Sell |
-1,773
| Closed | -$141K | – | 483 |
|
|
2013
Q3 | $141K | Hold |
1,773
| – | – | 0.01% | 270 |
|
|
2013
Q2 | $129K | Buy |
+1,773
| New | +$129K | 0.01% | 273 |
|